Andrew J. Muratore
InvestorVice President & Chief Counsel, M&A and Licensing at Pfizer Venture Investments
About
Andrew J. Muratore is Vice President and Chief Counsel, M&A and Licensing at Pfizer, where he has served as lead counsel to Pfizer Ventures since joining the company in 2008. He advises the Pfizer Ventures team on transactional matters, securities, compliance, and governance, and has led significant Pfizer M&A efforts including the acquisitions of Global Blood Therapeutics, Biohaven, Medivation and Hospira. He previously worked at Covington & Burling LLP and holds a J.D. from New York University and a B.A. from Colgate University.
Investments
Board seats
G-Con ManufacturingNeuroneticsPrescriber Point, Inc.
Per the firm's website.
Colleagues at Pfizer Venture Investments
Ama Amoah
Finance Director, Business Development at Pfizer Venture Investments
Anthony Barry
Executive Director, WWBD / Partner at Pfizer Venture Investments
Boyoon Choi
Senior Corporate Counsel at Pfizer Venture Investments
Christopher O'Donnell
Partner at Pfizer Venture Investments
Irena Melnikova
Executive Director, WWBD / Partner at Pfizer Venture Investments
Marie-Claire Peakman
Executive Director, WWBD / Partner at Pfizer Venture Investments
Michael C. Diem
Vice President, WWBD / Senior Managing Partner at Pfizer Venture Investments
Rana Al-Hallaq
Partner at Pfizer Venture Investments
Frequently asked questions
- Where does Andrew J. Muratore work?
- Andrew J. Muratore is Vice President & Chief Counsel, M&A and Licensing at Pfizer Venture Investments.